KMB
Published on 04/28/2026 at 06:52 am EDT
Q1 2026 Earnings
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S
April 28, 2026
BABY CARE WOMEN'S HEALTH ACTIVE AGING
CORE BUSINESS MOMENTUM
GENERATIONAL VALUE CREATION OPPORTUNITY
KENVUE
ACQUISITION
Successfully Transforming Differentiated Capabilities Core Financial Strength
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 3
P OWERING CA RE
Q1 2026: Sustaining Strong Base Business Momentum
Out-Innovate | Out-Market
Out-Activate
Strong volume/mix-led
organic growth delivery
Held global weighted share in the quarter vs. baseline, while navigating a dynamic environment
Best Product, Lowest Cost
Continued momentum
on Gross Productivity
Managing input cost volatility while expanding operating margins
Fast & Agile
Operating Model
Overhead efficiencies driving
strong Adjusted RSG&A1 leverage
Efficiently and effectively navigating new, discreet headwinds
1Non-GAAP financial measures. Refer to the appendix of this presentation for reconciliations of our GAAP to non-GAAP measures.
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S
4
Our Powering Care Strategy Is Sustaining Top-Line Momentum
Volume + Mix
2.6%
P OWERING CA RE
3.0%
Building on 2 consecutive years of broad-based volume-plus-mix growth
(0.7%)
1.0%
(1.6%)
FY22 FY23 FY24 FY25 Q1'26
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S
5
We're Delivering a Surge
of Growth Initiatives in Q2
We're Delivering More and Faster Innovation Than Ever Before
P OWERING CA RE
OUT-INNOVATE
2024/2025
~60%
of total Net Sales from Innovation1
>75%
of Organic Growth from Innovation1
OUT-ACTIVATE
OUT-MARKET
2026
+50%
increase in
market reach for key
innovations2
2026 - 2028
1.6x
2x
Expected NSV contribution from Q2'26 launches3
Cumulatively across FY 2024 and 2025
2026 vs. 2022-2023 average
Q2 2026 NSV contribution vs 2022 - 2025 quarterly average.
2026 3 YR pipeline value vs. 2020
increasing 3YR
Pipeline Value4
6
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 6
Sustaining Industry-Leading Gross Productivity Savings
BEST
P RODUCT, LOWEST
COST
Q 1 2 0 2 6
On Track for 3rd Year of ~6% Gross Productivity Savings in 20262
of Adj COGS1
Value Stream:
Design to Value initiatives including standardized product platforms and strong price negotiations unlocking value
Network Optimization:
Optimizing manufacturing and distribution footprint including external contract manufacturing among others
Scalable Automation:
Gross Productivity includes Productivity generated from end-to-end Integrated Margin Management and from Procurement initiatives
Unlocking efficiencies through automation
1Non-GAAP financial measures. Refer to the appendix of this presentation for reconciliations of our GAAP to non-GAAP measures. 2Kimberly-Clark does not provide a reconciliation of these forward-looking non-GAAP financial measures to the most directly comparable GAAP financial measures on a forward-looking basis because it is unable to predict certain adjustment items without unreasonable effort.
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 7
Building Momentum Toward Acquisition
Scaled Consumer Health &
Wellness Company with:
~$32B+
Revenue1
~$7B
Great Progress
Toward Day 1
Excited to establish
post-close leadership team, lean-and-agile organization structure
Encouraged by Kenvue
operational progress
Building greater visibility on future earnings power of combined company
EBITDA1 Pre-Synergies
Building the Future of Consumer-Centric Care for All
Leading
Baby Care
Pioneering
Active Aging
Advancing
Women's Health
Reflects the estimated 2025 results for the combined companies, as reported in the joint proxy statement/prospectus filed on form S-4 on December 4, 2025, and as amended on December 12, 2025. EBITDA Pre-synergies is a non-GAAP financial measure. Refer to the previously mentioned Form S-4 filings for further information on this non-GAAP financial measure.
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S
8
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S
SEGMENT RESULTS & HIGHLIGHTS
North America
Organic Growth1 Operating Profit Growth
1.8%
(8.1%)
Q1'26 Q1'26
Strong volume+mix led organic growth in a
challenging, value-conscious, consumer environment
Broad-based volume growth with strong performance in Baby and Child Care of +5%
Q1 weighted share broadly in line with year ago while personal care categories grew value share +20 bps led by volume share gains of +60 bps
Lower operating profit and margin versus strong year ago, as productivity savings and volume-driven gains were more than offset by a 490 bps headwind from business exits as well as stepped-up
brand investments
+1.7%
VOLUME + MIX
23.5%
OPERATING MARGIN
1. Non-GAAP financial measure. Refer to the appendix of this presentation for reconciliations of our GAAP to non-GAAP measures.
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 10
North America: Market Share + Margin Momentum
C O U N T R Y : C A T E G O R Y " C E L L " A S S E S S M E N T :
% O F N E T S A L E S G A I N I N G / H O L D I N G S H A R E 1
18 Cells, Net Sales Weighted2
Innovation to drive best
performance at the lowest cost
Breakthrough marketing to build
brand love
Differentiated value
propositions across price:value tiers, channels, and markets
23.7% 23.5%
32%
22.9%
67%
95%
2023 2025 Q1'26
1Share changed measured 2023 vs. 2022, 2025 vs 2023, Q1 2026 (MAT) vs 2025
2 Weighted K-C net sales based on FY 2025
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S
11
U.S.: Driving Growth in Facial Tissue with Kleenex Innovation
OUT-
INNOVA TE
1. g
U.S. FACIAL TISSUE
+180 bps
L3M Market Share vs.
year ago
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 12
"Don't Be Afraid":
Breaking the Stigma with Depend
OUT-MA RKET
U.S. DEPEND1
+80 bps
L3M Market Share vs. year ago
+190 bps
L3M Consumption Growth Ahead of Category
Deion Sanders
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S
Coach Prime
1 Values based on All Outlet data for Adult Care HE
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 13
OUT-
INNOVA TE
U.S.: End-to-End Kotex Relaunch Leveraging Breakthrough Gravity Technology
GRAVITY SCALED IN TOP MARKETS AND ENTERPRISE MARKETS
Powered by Gravity Core Technology
*breathability, odor control, dryness, fit, and leakage protection
Rapidly pulls blood to the bottom of the pad to help women feel clean, dry, and protected
5X System with LeakShield
Delivers breathability, odor control, dryness, fit, and reliable leak protection
Bamboo
UltraSoft and breathable viscose top layer made from organically-grown bamboo
BioCare
pH Proactive System helps defend against odor and irritants
Night DefenseĀ®
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S
Designed with revolutionary side guards and a raised back bumper to help prevent back and side leaks
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S
14
"Own Your Flow":
New Global Kotex Platform
OUT-MA RKET
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 15
International Personal Care
Organic Growth1 Operating Profit Growth
21.9%
4.0%
Strong volume+mix led organic growth with Focus Markets +5% and Enterprise Markets +2%
Baby Care in Focus Markets grew double-digit organic growth in the quarter
Continued share momentum in Focus Markets led by growth in Diapers C Pants in Indonesia +320 bps, China
+180 bps, Brazil +40 bps; Indonesia Fem Care +310 bps, and Australia Adult Care +230 bps
Strong operating profit growth driven by productivity
gains, volume-driven net sales growth, and overhead
Q1'26
Q1'26
efficiencies
+5.5%
VOLUME + MIX
16.2%
OPERATING MARGIN
1. Non-GAAP financial measure. Refer to the appendix of this presentation for reconciliations of our GAAP to non-GAAP measures.
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 16
International Personal Care: Market Share + Margin Momentum
% O F N E T S A L E S :
K E Y C E L L S G A I N I N G / H O L D I N G S H A R E 1
c1 Cells, Net Sales Weighted2
16.2%
84%
59%
52%
11.3%
14.0%
Innovation to drive best
performance at the lowest cost
Breakthrough marketing to build
brand love
Differentiated value
propositions across price:value
tiers, channels, and markets
2023 2025 Q1'26
1Share changed measured 2023 vs. 2022, 2025 vs 2023, Q1 2026 (MAT) vs 2025
2 Weighted K-C net sales based on FY 2025
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S
17
OUT-
INNOVA TE
Breakthrough material innovation with clear absorbency and
breathability benefits to keep babies drier and more comfortable.
Consumer Satisfaction
Product Rating
Breathability
300 Air Holes
Refreshing comfort with airflow
Absorbency
300 Instant Absorption Pockets with Max
Absorption Tech
Proven Product Superiority
Preferred
vs. Leading Competitor
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 18
Indonesia: Winning in Premium and Driving Performance Across Diapers Tiers
First in Indonesia!
OUT-
INNOVA TE
Indonesia Diapers s Pants
+320 bps
L3M Market Share vs. year ago
2 Special Zones to Separate Pee C Poo for No-Worry Irritation
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 19
Brazil: Taking Diapers
Share and Scaling Innovation
OUT-
INNOVA TE
2025 marked a milestone year enabled by portfolio relaunch
+1.9PP
Brand Equity
+22%
Premium growth sales
+40
bps
L3M Market Share vs year ago
Value Market Share
20.5
20.2
20.8 21.0
FY' 23 FY'24 FY'25 L3M '26
K I M B E R L Y - C L A R K | Q 1 2 0 2 6 E A R N I N G S 20
K I MBE R L Y - CL ARK | Q1 2 0 2 6 E ARN I NGS
Disclaimer
Kimberly-Clark Corporation published this content on April 28, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 28, 2026 at 10:51 UTC.